CN

Chidambaram Nalini Hemalatha

Active Director Director DIN 01288443
DIN 01288443 First appointment Jun 2006 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Chidambaram Nalini Hemalatha

Data last updated:

Chidambaram Nalini Hemalatha is a Director at Doctors Formulations Private Limited (since 2006). The company operates in Chemicals.

DIN 01288443
Primary Designation Director
Industry Chemicals
First Appointment 15 Jun 2006
Oldest Company Age 21 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Doctors Formulations Private Limited U24231TN2005PTC056051
Director15 Jun 20062005Active

Board colleagues of Chidambaram Nalini Hemalatha

Directorship timeline

Open interactive timeline →
Doctors Formulations Private Limited
Premium access

Shareholding and investment profile for Chidambaram Nalini Hemalatha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chidambaram Nalini Hemalatha

Chidambaram Nalini Hemalatha currently holds 1 directorship: Doctors Formulations Private Limited (Director, since 15 Jun 2006).

Chidambaram Nalini Hemalatha was first appointed on 15 Jun 2006 as Director at Doctors Formulations Private Limited.

The current boards of Chidambaram Nalini Hemalatha's companies include Chellaperumal Nagarajan Suresh (Doctors Formulations Private Limited), Narayanaswami Kaliammal (Doctors Formulations Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available